TABLE 3.
Effect of LPS pretreatment on blood leukocytes during serovar Typhimurium infectiona
Time (h) | Pretreatment | Total leukocytes (106/ml) | % PMN | % Lymphocytes | % Monocytes |
---|---|---|---|---|---|
1 | Control | 2.3 ± 1.6 | 18 ± 8 | 70 ± 11 | 9 ± 5 |
LPS i.p. | 5.2 ± 1.9b | 76 ± 6b | 14 ± 6c | 10 ± 2 | |
LPS i.v. | 2.9 ± 1.0 | 51 ± 8b | 35 ± 6c | 14 ± 4 | |
48 | Control | 1.2 ± 1.0 | 51 ± 14 | 34 ± 15 | 12 ± 8 |
LPS i.p. | 4.9 ± 2.4c | 61 ± 11 | 27 ± 7 | 10 ± 7 | |
LPS i.v. | 3.3 ± 1.3c | 68 ± 3 | 20 ± 4 | 12 ± 2 |
Mice were treated i.p. or i.v. with serovar Abortus equi LPS (1 mg/kg) three times at 24-h intervals. Twenty-four hours after the last LPS injection, LPS-tolerant mice and saline-pretreated controls were infected with serovar Typhimurium (107 bacteria/kg i.p.). Total and differential counts of blood leukocytes were performed 1 and 48 h after infection. Data are expressed as means ± SD (n = 9 for saline controls and n = 6 for the LPS groups).
Significantly different from saline control (P < 0.05).
Significantly different from control (P < 0.01).